Non-coding recurrent mutations in chronic lymphocytic leukaemia

Area of Science:

• Genomics
• Oncology
• Molecular Biology

Background:

• Chronic lymphocytic leukemia (CLL) is a common hematologic malignancy.
• The genetic underpinnings of CLL's diverse clinical behaviors are not fully elucidated.

Purpose of the Study:

• To comprehensively analyze the genomic landscape of CLL and its precursor, monoclonal B-lymphocytosis.
• To identify novel driver mutations and understand their impact on disease progression and clinical outcomes.

Main Methods:

• Whole-genome sequencing and analysis of 452 CLL cases and 54 monoclonal B-lymphocytosis samples.
• Identification and functional characterization of recurrent mutations in coding and non-coding regions.

Main Results:

• Extended the repertoire of CLL driver alterations, including mutations in ZNF292, ZMYM3, ARID1A, and PTPN11.
• Discovered novel non-coding mutations in the NOTCH1 3' region, leading to aberrant splicing and increased NOTCH1 activity, correlating with aggressive disease.
• Identified mutations in a 9p13 enhancer reducing PAX5 expression, a key B-cell transcription factor.
• Demonstrated that the cumulative number of driver alterations effectively discriminates between patient clinical behaviors.

Conclusions:

• Provides an integrated genomic portrait of CLL, revealing new recurrent driver mutations.
• Highlights the significance of non-coding mutations in CLL pathogenesis.
• Suggests potential therapeutic targets and improved patient stratification strategies for CLL management.